Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.

Ann Rheum Dis. 2016 Nov 24. pii: annrheumdis-2016-209519. doi: 10.1136/annrheumdis-2016-209519. [Epub ahead of print]

PMID:
27884822
2.

Microvesicles in Autoimmune Diseases.

Liu ML, Williams KJ, Werth VP.

Adv Clin Chem. 2016;77:125-175. doi: 10.1016/bs.acc.2016.06.005.

PMID:
27717416
3.

Biological therapies in the treatment of cutaneous lupus erythematosus.

Presto JK, Hejazi EZ, Werth VP.

Lupus. 2016 Sep 29. pii: 0961203316670731. [Epub ahead of print] Review.

PMID:
27687023
4.

Addison Disease and Discoid Lupus Erythematosus: A Rare Association of Polyglandular Autoimmune Syndrome Type II.

Baumrin E, Webster G, Werth VP.

J Clin Rheumatol. 2016 Oct;22(7):382-3. doi: 10.1097/RHU.0000000000000376. No abstract available.

PMID:
27660939
5.

Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation.

Gui J, Gober M, Yang X, Katlinski KV, Marshall CM, Sharma M, Werth VP, Baker DP, Rui H, Seykora JT, Fuchs SY.

J Invest Dermatol. 2016 Oct;136(10):1990-2002. doi: 10.1016/j.jid.2016.06.608.

PMID:
27369778
6.

Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Fett NM, Fiorentino D, Werth VP.

Dermatol Clin. 2016 Jul;34(3):243-50. doi: 10.1016/j.det.2016.02.006. Review.

PMID:
27363879
7.

The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP).

Robinson ES, Payne AS, Pappas-Taffer L, Feng R, Werth VP.

J Am Acad Dermatol. 2016 Jul;75(1):42-8. doi: 10.1016/j.jaad.2016.02.1153.

PMID:
27317514
8.

Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis.

Ang CC, Anyanwu CO, Robinson E, Okawa J, Feng R, Fujimoto M, Hamaguchi Y, Werth VP.

Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14801. [Epub ahead of print] No abstract available.

PMID:
27292591
9.

Erratum to "Severity score indexes for blistering diseases" [Clin Dermatol 2011:30 108-113].

Daniel BS, Hertl M, Werth VP, Eming R, Murrell DF.

Clin Dermatol. 2016 May-Jun;34(3):430-431. doi: 10.1016/j.clindermatol.2016.03.002. No abstract available.

PMID:
27265085
10.

Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum.

Wan J, Imadojemu S, Werth VP.

Clin Dermatol. 2016 May-Jun;34(3):344-52. doi: 10.1016/j.clindermatol.2016.02.006.

PMID:
27265072
11.

Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Chang J, Werth VP.

Expert Rev Clin Immunol. 2016 Oct;12(10):1109-21. doi: 10.1080/1744666X.2016.1188006.

PMID:
27249209
12.

Pulmonary function tests, interstitial lung disease, and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis.

George MD, Shah R, Kreider M, Miller WT Jr, Merkel PA, Werth VP.

Br J Dermatol. 2016 May 27. doi: 10.1111/bjd.14771. [Epub ahead of print]

PMID:
27229750
13.

How Can We Promote Physician-Directed Research in Complex Medical Dermatology?

Werth VP, Hordinsky M.

J Invest Dermatol. 2016 May;136(5):885-7. doi: 10.1016/j.jid.2016.02.017. No abstract available.

PMID:
27107372
14.

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.

Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, Drappa J, Wang L, Greth W; CD1067 study investigators..

Ann Rheum Dis. 2016 Nov;75(11):1909-1916. doi: 10.1136/annrheumdis-2015-208562.

15.

Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Chen Y, Li G, Liu Y, Werth VP, Williams KJ, Liu ML.

J Cell Physiol. 2016 Nov;231(11):2319-26. doi: 10.1002/jcp.25352.

PMID:
26909509
17.

Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.

Hejazi EZ, Werth VP.

Am J Clin Dermatol. 2016 Apr;17(2):135-46. doi: 10.1007/s40257-016-0173-9. Review.

PMID:
26872954
18.

Treatment of cutaneous lupus erythematosus: current practice variations.

Reich A, Werth VP, Furukawa F, Kuhn A, Szczęch J, Samotij D, Szepietowski JC.

Lupus. 2016 Aug;25(9):964-72. doi: 10.1177/0961203316628997.

PMID:
26821963
19.

Ice-pack Dermatosis: A Diagnositic Pitfall for Dermatopathologists that Mimics Lupus Erythematosus.

Haber JS, Ker KJ, Werth VP, Rubin A.

J Cutan Pathol. 2016 Jan;43(1):1-4. doi: 10.1111/cup.12658. No abstract available.

PMID:
26818895
20.

Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.

Boulard C, Duvert Lehembre S, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B, Vabres P, Borradori L, Prost-Squarcioni C, Labeille B, Richard MA, Ingen-Housz-Oro S, Houivet E, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; International Pemphigus Study Group..

Br J Dermatol. 2016 Jul;175(1):142-9. doi: 10.1111/bjd.14405.

PMID:
26800395
Items per page

Supplemental Content

Loading ...
Support Center